Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:BIOCONCapital Goods
Clear all filters
Dividend Stocks To Watch Next Week: Bajaj Finance, M&M, Tech Mahindra, Welspun Corp, Biocon — Check Amount, Record Date
positive
NDTV Profit 13d ago

Dividend Stocks To Watch Next Week: Bajaj Finance, M&M, Tech Mahindra, Welspun Corp, Biocon — Check Amount, Record Date

Dividend Stocks to Watch

BAJAJHFLBAJFINANCEBIOCONDIVIDENDLTFM&MNEXT50ETFTECHTECHMWELCORPWELENTZTECHAutomobile and Auto ComponentsCapital Goods
Buy or sell: Gift Nifty signals gap-up opening, Vaishali Parekh recommends three stocks to buy today — 23 June 2026
positive
LiveMint - Markets 18d ago

Buy or sell: Gift Nifty signals gap-up opening, Vaishali Parekh recommends three stocks to buy today — 23 June 2026

Buy or sell stocks, 23 June 2026: Vaishali Parekh recommends three stocks to buy today — Hindustan Zinc, Biocon, and Adani Green Energy 

ADANIENSOLADANIENTADANIGREENAXISBPSETFBIOCONENERGYGKENERGYHINDZINCINOXGREENKPELKPIGREENMOENERGYNTPCGREENSAATVIKGLSDL26BEESVAISHALICapital GoodsConstruction
Biocon eyes crown of world’s top insulin supplier amid rush for GLP-1
positive
LiveMint - Companies 25d ago

Biocon eyes crown of world’s top insulin supplier amid rush for GLP-1

Biocon, currently the third-largest insulin supplier by volume, has invested “big time” in ramping up production capacity, Chairperson Kiran Mazumdar-Shaw says.

BIOCONCROWNCapital GoodsHealthcare
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for Biocon
neutral
ET Markets - Industry 25d ago

Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for Biocon

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalizing on growing demand as major pharmaceutical companies shift focus to newer weight-loss drugs. Currently the third-largest global insulin provider, Biocon is significantly expanding production. This strategic move addresses a critical gap in the market, particularly in emerging economies.

BIOCONCROWNFOCUSGLOBALSDL26BEESTOP10ADDTOP15IETFTOP20Capital GoodsConsumer Durables
Insider trading: Supreme Court upholds SAT clearance to Biocon MD
positive
ET Markets - Industry 31d ago

Insider trading: Supreme Court upholds SAT clearance to Biocon MD

The Supreme Court has backed a tribunal's decision, clearing Biocon's managing director, Shreehas P Tambe, of insider trading allegations from 2017. The Securities and Exchange Board of India's appeal was rejected. Tambe was accused of trading Biocon shares while possessing unpublished price-sensitive information.

BIOCONSUPREMESUPREMEINDSUPREMEINFCapital GoodsConstruction
Five Stocks To Buy: ONGC, NTPC Green, Biocon And More | May 14, 2026
positive
NDTV Profit 58d ago

Five Stocks To Buy: ONGC, NTPC Green, Biocon And More | May 14, 2026

Top picks include bullish setups in ONGC, NTPC Green Energy, South West Pinnacle, Amber Enterprises, and Biocon.

ADANIGREENAMBERBIOCONENERGYGKENERGYINOXGREENKPELKPIGREENNTPCNTPCGREENONGCSAATVIKGLSDL26BEESSOUTHWESTCapital GoodsConstruction
​Technical stock picks! 3 shares that could give up to 15% return this May. Do you own any?
positive
ET Markets - Stocks 59d ago

​Technical stock picks! 3 shares that could give up to 15% return this May. Do you own any?

​Following a recent downtrend, the Nifty has seen a rally, with analysts suggesting a buy-on-dips strategy. Three technical stock picks from Axis—KEI Industries, Grasim Industries, and Biocon—are highlighted, each with potential upside returns of up to 15% for May.​

AXISBPSETFBIOCONBNKETFAXISCONSUMAXISGRASIMHEALTHAXISITAXISKEINIFTYAXISCapital GoodsConstruction Materials
Tata Consumer among 5 F&O stocks with a sharp rise in futures open interest
positive
ET Markets - Stocks 60d ago

Tata Consumer among 5 F&O stocks with a sharp rise in futures open interest

Five NSE F&O stocks, Dalmia Bharat, Tata Consumer Products, Kaynes Technology India, Bharti Airtel and Biocon, recorded sharp futures open interest gains on May 11, signalling increased trader participation and fresh positioning activity.

BHARTIARTLBIOCONCONSUMERDALBHARATDALMIASUGGANESHCPGODREJCPJUBLCPLKAYNESLIBASMBAPLTATACONSUMTATATECHCapital GoodsChemicals
Promoter Shareholding: Godrej Properties, Adani Energy see stake hike; BHEL, Vishal Mega Mart, Biocon face cuts
positive
LiveMint - Markets 65d ago

Promoter Shareholding: Godrej Properties, Adani Energy see stake hike; BHEL, Vishal Mega Mart, Biocon face cuts

Promoter Shareholding: The companies that recorded an increase in promoter ownership between the December 2025 and March 2026, Godrej Properties saw promoter holding rise from 47.2% to 51.7%, while Adani Energy Solutions witnessed an increase from 71.2% to 72.7%.

ADANIENSOLADANIENTADANIGREENBHELBIOCONENERGYGKENERGYGODREJINDGODREJPROPKPELSGMARTVMMCapital GoodsConstruction
Bharat Forge, Biocon, Dabur, Escorts Kubota, Lupin, MRF, Pidilite Industries Q4 Results Today — Earning Estimates
positive
NDTV Profit 65d ago

Bharat Forge, Biocon, Dabur, Escorts Kubota, Lupin, MRF, Pidilite Industries Q4 Results Today — Earning Estimates

Bharat Forge is expected to report profit at Rs 369.8 crore and revenue at Rs 4,559.97 crore.

BHARATFORGBIOCONDABURESCORTSLUPINMRFPIDILITINDAutomobile and Auto ComponentsCapital Goods
Stocks in news: Biocon, PB Fintech, Polycab India, South Indian Bank, Shree Cement, Kaiser Corp, ACME... - Moneycontrol.com
neutral
Google News - India Markets 65d ago

Stocks in news: Biocon, PB Fintech, Polycab India, South Indian Bank, Shree Cement, Kaiser Corp, ACME... - Moneycontrol.com

Stocks in news: Biocon, PB Fintech, Polycab India, South Indian Bank, Shree Cement, Kaiser Corp, ACME...Moneycontrol.com

BANKINDIABIOCONINDIANBIOBJKCEMENTPOLICYBZRPOLYCABSHREDIGCEMSHREECEMSOUTHBANKCapital GoodsConstruction Materials
Biocon rolls out two biosimilars in US market
positive
ET Markets - Industry 95d ago

Biocon rolls out two biosimilars in US market

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They are now available through specialty pharmacies and healthcare providers. The US Food and Drug Administration previously approved them. This launch expands Biocon's portfolio and aims to provide affordable treatment options for patients.

AFFORDABLEBIOCONHCGHCG-REHEALTHCAREVIDHIINGCapital GoodsChemicals
2
Next